News

Retatrutide and MOTS-c for Metabolic Flexibilit...

Retatrutide and MOTS-c are being studied for metabolic flexibility. Applying the VA's sequential GLP-1 trial logic could enhance weight loss by targeting

Semaglutide Misuse and Compounded Peptide Purit...

NBC 5 Chicago's semaglutide misuse warning reveals that compounded peptide purity alone cannot prevent dosing errors. Learn what the research says

Retatrutide and Tesamorelin Stack for Belly Fat...

Retatrutide and tesamorelin show promise for stubborn belly fat, but an FDA panel vote tightens access. Learn what the regulatory shift means for

Retatrutide vs. Tirzepatide for Appetite Contro...

Retatrutide and tirzepatide both suppress appetite, but retatrutide's triple agonism adds a glucagon-driven satiety signal. Learn how they compare in

Retatrutide and Menstrual Cycle Changes: What t...

Retatrutide's triple agonism may influence menstrual cycles through rapid weight loss and hormonal shifts. This article examines safety data, mechanisms

Retatrutide's Triple Agonism and GI Tolerance A...

Retatrutide's triple agonism may reduce GI side effects when restarting weight loss treatment after a break like Ramadan. Learn how GIP and glucagon